2016
DOI: 10.1016/j.jelechem.2016.03.040
|View full text |Cite
|
Sign up to set email alerts
|

Development of a bio-electrochemical immunosensor based on the immobilization of SPINNTKPHEAR peptide derived from HPV-L1 protein on a gold electrode surface

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
11
0
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 21 publications
(12 citation statements)
references
References 23 publications
0
11
0
1
Order By: Relevance
“…Based in our previous results [ 17 ], we designed two peptides: HPV-2 and HPV-3. Both of them contain: (i) an antigenic sequence (underlined); (ii) a cysteine residue, which was introduced since it is well-known that compounds containing thiol groups are strongly coordinated with a variety of metals, including gold, silver, platinum, and copper [ 28 , 29 ].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Based in our previous results [ 17 ], we designed two peptides: HPV-2 and HPV-3. Both of them contain: (i) an antigenic sequence (underlined); (ii) a cysteine residue, which was introduced since it is well-known that compounds containing thiol groups are strongly coordinated with a variety of metals, including gold, silver, platinum, and copper [ 28 , 29 ].…”
Section: Resultsmentioning
confidence: 99%
“…In this context, we previously designed a bioelectrochemical immunosensor; specifically, the synthetic peptide HPV-1: Fc–Ahx–SPINNTKPHEAR was physically immobilized on a gold electrode, and the coating was done through the drop-casting method, using the Nafion polymer. HPV-1 was designed containing a ferrocene probe, a spacer, and a sequence derived from L1-HPV protein [ 17 ]. The electrochemical behavior of the modified electrode was examined via cyclic voltammetry in order to evaluate the redox behavior of the ferrocene moiety.…”
Section: Introductionmentioning
confidence: 99%
“…Especially the electrochemical immunosensors have emerged as an alternative diagnostic methods for the traditional clinical assays in medical diagnostics and pandemic diseases management ( Hussein et al, 2020 ; Ranjan et al, 2021 ; Torrente-Rodríguez et al, 2020 ). This section summarizes the sensor systems in which the recognition matrix is comprised of antibodies for the selective electrochemical detection of hepatitis A ( Mandli et al, 2017 ), of hepatitis B ( Akkapinyo et al, 2020 ; Wei et al, 2020 ), of hepatitis C ( Zhao and Liu, 2016 ), five types of hepatitis ( Tang et al, 2010 ), HPV ( Piro et al, 2011 ; Valencia et al, 2016 ; Zari et al, 2009 ), HIV ( Akkapinyo et al, 2020 ; Macchia et al, 2020 ), Zika ( Cabral-Miranda et al, 2018 ; Draz et al, 2018 ; Faria and Mazon, 2019 ; Kaushik et al, 2018 ), Dengue ( Cheng et al, 2012 ; Nawaz et al, 2018 ), Rotavirus ( Attar et al, 2016 ; Liu et al, 2013 ) and Influenza virus ( Zhou et al, 2013 ).…”
Section: Electrochemical Diagnosticsmentioning
confidence: 99%
“… S NO Virus Recognition Matrix Method Concentration Range LOD Ref 1 HAV Carbon nanopowder paste electrode/antibody labeled with peroxidase Chronoamperometry 2×10 -4 – 5×10 -3 IU. mL -1 26 ×10 -5 IU mL -1 ( Mandli et al, 2017 ) 2 HPV Au peptide (SPINNTKPHEAR) linked to a 6-aminohexanoic (Ahx) residue and ferrocene (Fc) Chronoamperometry 0.010–0.020 μg L −1 0.010 μg L −1 ( Valencia et al, 2016 ) 3 HPV GCE/anti HPV-16-L1:anti-HPV complex SWV - 0.1 nmol dm −3 ( Piro et al, 2011 ) 4 HPV SCPGE/DNA SWV 0–5 ng mL -1 0.3 ng mL -1 ( Zari et al, 2009 ) 5 HBV Graphene paste electrode|Au NPs/Nafion-cysteine/Antibody DPV 0.5–200 ng mL -1 0.01 ng mL -1 ( Huang et al, 2012 ) 6 HBV SPCE/Graphene Oxide/Fe 3 O 4 /Prussian Blue Nanocomposites/Antibody DPV 0.5 pg mL -1 - 200 ng mL -1 0.166 pg mL -1 ( Wei et al, 2020 ...…”
Section: Electrochemical Diagnosticsmentioning
confidence: 99%
“…The International Agency for Research on Cancer (IARC) estimates that the number of cases of invasive cervical cancer in 2020 was 557,088 with more than 297,122 deaths caused by the disease. On incidence rates, cervical cancer was the third most common female cancer in the world in 2018 [ 1 ] and, after breast cancer and colorectal cancer, is the third leading cause of death in women worldwide [ 2 ]. HPV infection is a well-established cause of cervical cancer, and there is growing evidence that could be relevant in other anogenital cancers such as anal, vulval, vaginal, and penile, in addition to head and neck cancers [ 3 ].…”
Section: Introductionmentioning
confidence: 99%